Compare MTEN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTEN | SCNX |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 24.8M |
| IPO Year | 2024 | 2020 |
| Metric | MTEN | SCNX |
|---|---|---|
| Price | $0.59 | $0.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 169.5K | ★ 1.7M |
| Earning Date | 10-01-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,735,337.00 | $653,391.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 16.63 | ★ 207.88 |
| 52 Week Low | $0.52 | $0.46 |
| 52 Week High | $26.03 | $8.19 |
| Indicator | MTEN | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 16.97 | 38.55 |
| Support Level | $0.52 | $0.50 |
| Resistance Level | $1.26 | $0.75 |
| Average True Range (ATR) | 0.22 | 0.06 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 7.16 | 0.52 |
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.